Literature DB >> 29486015

Gabapentin for Chronic Neuropathic Pain.

Andrew Moore1, Sheena Derry1, Philip Wiffen1.   

Abstract

Clinical Question: Is gabapentin associated with pain relief in people with chronic neuropathic pain? Bottom Line: Oral gabapentin (1200-3600 mg/d for 4-12 weeks) for patients with moderate or severe neuropathic pain from postherpetic neuralgia (PHN) or painful diabetic neuropathy (PDN) is associated with pain reduction of at least 50% in 14% to 17% more patients than placebo.

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29486015     DOI： 10.1001/jama.2017.21547

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


  16 in total

Review 1.  Peripheral neuropathy in children and adolescents treated for cancer.

Authors:  Kari L Bjornard; Laura S Gilchrist; Hiroto Inaba; Barthelemy Diouf; Marilyn J Hockenberry; Nina S Kadan-Lottick; Daniel C Bowers; M Eileen Dolan; Nicole J Ullrich; William E Evans; Kirsten K Ness
Journal:  Lancet Child Adolesc Health       Date:  2018-09-01

2.  Gabapentin Use for Hospitalized Neonates.

Authors:  Hibo H Abdi; Nathalie L Maitre; Kristen L Benninger; Mark E Hester; Jonathan L Slaughter
Journal:  Pediatr Neurol       Date:  2019-02-21       Impact factor: 3.372

Review 3.  Comprehensive Review of Topical Analgesics for Chronic Pain.

Authors:  Jillian Maloney; Scott Pew; Christopher Wie; Ruchir Gupta; John Freeman; Natalie Strand
Journal:  Curr Pain Headache Rep       Date:  2021-02-03

Review 4.  [Pain treatment in old age: special features and recommendations].

Authors:  Georg Pinter; Waltraud Stromer; Josef Donnerer; Svetlana Geyrhofer; Burkhard Leeb; Nenad Mitrovic; Katharina Pils; Ruldolf Likar
Journal:  Z Gerontol Geriatr       Date:  2020-07-17       Impact factor: 1.281

5.  Effectiveness of Short-term Use of Gabapentin as Pre-emptive Analgesia in Reducing Pain after Video Assisted Thoracoscopic Surgery.

Authors:  Media Shamsaddini; Ramin Abrishami; Behrooz Farzanegan; Shadi Baniasadi
Journal:  Tanaffos       Date:  2022-01

6.  Trends in Gabapentin Prescribing in a Commercially Insured U.S. Adult Population, 2009-2016.

Authors:  Nathan J Pauly; Chris Delcher; Svetla Slavova; Eric Lindahl; Jeff Talbert; Patricia R Freeman
Journal:  J Manag Care Spec Pharm       Date:  2020-03

7.  Regulating gabapentin as a drug of abuse: A survey study of Kentucky community pharmacists.

Authors:  James Blackmer; Eric Lindahl; Audra Strahl; Aric Schadler; Patricia R Freeman
Journal:  J Am Pharm Assoc (2003)       Date:  2019-02-18

8.  Gabapentin-induced drug-seeking-like behavior: a potential role for the dopaminergic system.

Authors:  Yusuf S Althobaiti; Amal Alghorabi; Fahad S Alshehri; Bandar Baothman; Atiah H Almalki; Hashem O Alsaab; Walaa Alsanie; Ahmed Gaber; Hussam Almalki; Abdulrahman S Alghamdi; Ahmad Basfer; Sultan Althobaiti; Ana Maria Gregio Hardy; Zahoor A Shah
Journal:  Sci Rep       Date:  2020-06-26       Impact factor: 4.379

Review 9.  Tapentadol for neuropathic pain: a review of clinical studies.

Authors:  Ulderico Freo; Patrizia Romualdi; Hans G Kress
Journal:  J Pain Res       Date:  2019-05-16       Impact factor: 3.133

10.  Restoring invisible and abandoned trials of gabapentin for neuropathic pain: a clinical and methodological investigation.

Authors:  Evan Mayo-Wilson; Xiwei Chen; Riaz Qureshi; Stephanie Dickinson; Lilian Golzarri-Arroyo; Hwanhee Hong; Carsten Görg; Tianjing Li
Journal:  BMJ Open       Date:  2021-06-30       Impact factor: 2.692
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.